Patents by Inventor John Hunter Seely

John Hunter Seely has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of herpes simplex infections
    Patent number: 4092412
    Abstract: A method of treating herpes simplex infections in warm-blooded animals by administering to said animals a carboxylic ester of phosphonoacetic acid of the formula ##STR1## wherein R is a C.sub.1 -C.sub.2 alkyl.
    Type: Grant
    Filed: April 14, 1977
    Date of Patent: May 30, 1978
    Assignee: Abbott Laboratories
    Inventors: James Chieh-Hsia Mao, John Hunter Seely, John Scott Fairgrieve
  • Treatment of a mammary or DMBA inducible tumor
    Patent number: 4071622
    Abstract: Certain nonapeptide amides were found which, upon administration at daily dosages of from about 1-200 .mu.g/kg to warm-blooded animals, cause regression of DMBA-inducible or mammary tumors without causing adverse effects on healthy tissues.
    Type: Grant
    Filed: February 11, 1976
    Date of Patent: January 31, 1978
    Assignee: Abbott Laboratories
    Inventors: Edwin Samuel Johnson, John Hunter Seely
  • [Des-gly].sup.10 -GnRH nonapeptide anide analogs in position 6 having ovulation-inducing activity
    Patent number: 4005063
    Abstract: An unnatural nonapeptide with improved biological activities surpassing those of the natural follicle-stimulating lutenizing hormone-releasing hormone (Gn--RH) is described. The new peptide induces ovulation in warm-blooded animals at an oral dose of 5-100 .mu.g./kg.
    Type: Grant
    Filed: May 15, 1975
    Date of Patent: January 25, 1977
    Assignee: Abbott Laboratories
    Inventors: Ronald Lee Gendrich, Riemond Henry Rippel, John Hunter Seely
  • Treatment of specified neoplasias
    Patent number: 4002738
    Abstract: A series of nonapeptide amides has been found which, upon administration at daily dosages of from about 1-200 .mu.g/kg to warm-blooded animals, cause regression and subsequent elimination of certain tumors without causing adverse effects on healthy tissues.
    Type: Grant
    Filed: May 30, 1975
    Date of Patent: January 11, 1977
    Assignee: Abbott Laboratories
    Inventors: Edwin Samuel Johnson, John Hunter Seely